Jump to page content

Search results

  • News BIH Academy

    "Nanoranger" characterizes leukemia cells at the single-cell level using long-read sequencing.

    Single-cell RNA sequencing (scRNA-seq) has expanded our ability to distinguish cell populations and elucidate their interactions with each other. However, there are still difficulties in distinguishing leukemia cells from normal hematopoiesis based on gene expression alone. Livius Penter, BIH Digital Clinician Scientist Fellow and specialist at the…

  • News Charité BIH Innovation

    MoU signed for joint Co-Innovation Program with Enterprise Singapore

    On November 10, 2023 a significant milestone was reached when Charité - Universitätsmedizin Berlin, Berlin Institute of Health at Charité (BIH) and Enterprise Singapore signed a Memorandum of Understanding (MoU). This forms the basis for the upcoming launch of the Co-Innovation Program. This innovative program facilitates the professional…

  • News Charité BIH Innovation

    SPARK-BIH welcomes 12 new projects to the program

    Again, this year the SPARK-BIH funding and mentoring program motivated many scientists and clinicians from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) to submit their translational project proposals in the fields of pharma, diagnostics and medtech. The applicants presented their proposals to an expert…

  • News Charité BIH Innovation Digital Labs

    Next generation of digital health innovations presented at BIH Digital Health Accelerator Demo Day 2023

    On May 31, 2023, the sixth annual Demo Day of the BIH Digital Health Accelerator Program took place, bringing together a diverse group of innovative minds in the heart of Berlin. The event, hosted by the Berlin Institute of Health at Charité (BIH), showcased seven exceptional teams of Charité/BIH clinicians and researchers presenting their digital…

  • News BIH Academy

    Former BIH PhD student David Willnow publishes in Nature

    Former BIH translational PhD student David Willnow from the group of Prof. Francesca Spagnoli, Centre for Stem Cells and Regenerative Medicine, King's College London, London, UK, publishes Nature paper on „Quantitative lineage analysis identifies a hepato-pancreato-biliary progenitor niche“.

Press contact

Pressekontakt / Press contact

Katharina Kalhoff: +49 1515 7579574

Ole Kamm: +49 1522 5610126

Contact information